Cargando…

Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma

BACKGROUND: Malignant pleural mesothelioma (MPM) is an aggressive pleural malignancy, and despite all multimodal treatment modalities, the 5-year overall survival rate of patients with MPM is less than 20%. In the present study, we aimed to analyze the surgical and prognostic outcomes of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayan, Muhammet, Bas, Aynur, Turk, Merve Satir, Ozkan, Dilvin, Celik, Ali, Kurul, İsmail Cuneyt, Tastepe, Abdullah Irfan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Thoracic and Cardiovascular Surgery 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579847/ https://www.ncbi.nlm.nih.gov/pubmed/36068966 http://dx.doi.org/10.5090/jcs.22.037

Ejemplares similares

Prognostic Analysis of Primary Pulmonary Malignant Mesenchymal Tumors Treated Surgically
por: Sayan, Muhammet, et al.
Publicado: (2021)

Oxidized Regenerated Cellulose can be a Cause of False Tumor Recurrence on PET/CT in Patients with Lung Cancer Treated Surgically
por: Sayan, Muhammet, et al.
Publicado: (2023)

Prognostic factors for sarcomatoid carcinomas of lung: A single-centre experience
por: Sayan, Muhammet, et al.
Publicado: (2020)

A Rare Entity: Primary Pulmonary Meningioma
por: Baş, Aynur, et al.
Publicado: (2023)

Single-Center Experience of Management of Mediastinal Cyst—A Case Series
por: Gokce, Anil, et al.
Publicado: (2022)

Hemopneumothorax as an Unusual and Delayed Complication of Coronavirus Disease 2019 Pneumonia: A Case Report
por: Sayan, Muhammet, et al.
Publicado: (2021)

Metachronous Eosinophilic Granuloma of Rib in an Adult Patient
por: Ozkan, Dilvin, et al.
Publicado: (2021)

Simultaneous videothoracoscopic resection for thymoma and lung squamous cell carcinoma, and review of the literature
por: Sayan, Muhammet, et al.
Publicado: (2022)

Multimodality treatment of malignant pleural mesothelioma
por: Berzenji, Lawek, et al.
Publicado: (2018)

Multimodal treatment for resectable epithelial type malignant pleural mesothelioma
por: Yoshino, Ichiro, et al.
Publicado: (2004)

Improvement of Malignant Pleural Mesothelioma Prognosis: Early Diagnosis and Multimodality Treatment
por: Ban, Cheng-Jun, et al.
Publicado: (2017)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition
por: Ghanim, Bahil, et al.
Publicado: (2020)

Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients
por: Holzknecht, Arnulf, et al.
Publicado: (2022)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment
por: Aprile, Vittorio, et al.
Publicado: (2021)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma
por: Ebinç, Senar, et al.
Publicado: (2023)

Relapse Patterns and Tailored Treatment Strategies for Malignant Pleural Mesothelioma Recurrence after Multimodality Therapy
por: Bellini, Alice, et al.
Publicado: (2021)

Second Surgery for Recurrent Malignant Pleural Mesothelioma after Multimodality Treatment: A Systematic Review
por: Bellini, Alice, et al.
Publicado: (2022)

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
por: Woodard, Gavitt A., et al.
Publicado: (2020)

Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma
por: Kresoja-Rakic, Jelena, et al.
Publicado: (2017)

Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma
por: Tostes, Francinne T., et al.
Publicado: (2022)

Thoracoscopy in Pleural Malignant Mesothelioma Diagnosis
por: Tassi, G. F., et al.
Publicado: (1997)

Imaging in staging of malignant pleural mesothelioma
por: Truong, Mylene T, et al.
Publicado: (2004)

Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015)

Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017)

Modern management of malignant pleural mesothelioma
por: Patel, Shivani C, et al.
Publicado: (2016)

Pleural tuberculosis mimicking malignant mesothelioma
por: Dawood, Wajahat, et al.
Publicado: (2019)

Cytomegalovirus infection in malignant pleural mesothelioma
por: Hunter-Schlichting, DeVon, et al.
Publicado: (2021)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021)

Advances in Immunotherapy of Malignant Pleural Mesothelioma
por: Liao, Dongying, et al.
Publicado: (2021)

KRAS signaling in malignant pleural mesothelioma
por: Marazioti, Antonia, et al.
Publicado: (2021)

ECM Mechanoregulation in Malignant Pleural Mesothelioma
por: Panzetta, Valeria, et al.
Publicado: (2022)

Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020)

Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_stq1otqhp1t08niv7n966eq33s